The Standard in Pharmaceutical Industry Training & Credentialing

Winner of the 2020 IACET Exemplar Training Organization Award

The ACMA is the proud recipient of the International Association for Continuing Education and Training's 2020 annual Exemplar Training Organization award

Read more

ACMA Television Appearances

Discussing the Merck and J&J Merger

March 3, 2021

The ACMA frequently provides expertise about the pharmaceutical industry. In this video, CEO Dr. William Soliman speaks on Al Jazeera about the unprecendeted cooperation within the pharmaceutical industry to expedite the development of the covid-19 vaccine.

US Government Deal with Gilead Sciences

July 6, 2020

ACMA CEO Dr. William Soliman speaks on Al Jazeera to discuss the US Government's deal with Gilead Sciences to secure the COVID-19 vaccine. Is this a sign for things to come? Will patients in developing countries have adequate access to COVID-19 vaccines?

Discussing the $260MM Opioid Settlement

October 24, 2019

ACMA CEO Dr. William Soliman on Al Jazeera Newshour discusses how the $260 million opioid settlement is a wakeup call to Pharma companies. Dr. Soliman indicates that Pharma companies need to overhaul their “Old Ways” of training and preparing employees who are responsible for educating doctors and healthcare providers.

ACMA News Archive

Established Industry Experts